Highlights Aarti Drugs Limited

Equities

AARTIDRUGS

INE767A01016

Pharmaceuticals

Market Closed - Bombay S.E. Other stock markets 05:00:51 2026-01-22 EST			5-day change	1st Jan Change
374.85 ^INR	+0.21%		-4.07%	-8.98%

11-10	Aarti Drugs Limited, Q2 2026 Earnings Call, Nov 10, 2025
11-07	Aarti Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI

Highlights

11-07	Aarti Drugs Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025	CI
25-07-18	Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2025	CI
25-05-07	Aarti Drugs Consolidated Net Profit Jumps in Fiscal Q4	MT
25-05-06	Aarti Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2025	CI
25-05-06	Aarti Drugs March-Quarter Consol Net Profit 628.6 Mln Rupees	RE
25-02-14	US FDA Removes Import Alert on Aarti Drugs Limited's API Manufacturing Facility	CI
25-02-03	Ex-dividend day for interim dividend	FA
25-02-03	Aarti Drugs To Acquire 26.25% Equity In Pro-ZEAL Green Power Nine	RE
25-01-30	Aarti Drugs' Consolidated Net Profit Rises in Fiscal Q3	MT
25-01-29	Aarti Drugs Limited Declares Interim Dividend for the Financial Year 2024-25	CI
25-01-09	Aarti Drugs to Acquire 26% Stake in Renewable Energy Company	MT
24-11-17	Aarti Drugs Restores Manufacturing Actitvity at Tarapur, India Unit	MT
24-09-26	Tranche Update on Aarti Drugs Limited's Equity Buyback Plan announced on August 26, 2024.	CI
24-09-18	Aarti Drugs Limited's Equity Buyback announced on August 26, 2024 has closed with 665,000 shares, representing 0.72% for INR 598.5 million.	CI
24-08-26	Aarti Drugs Gets Board Nod to Buy Back Shares of Up to INR598.5 Million	MT
24-08-26	Aarti Drugs Limited announces an Equity Buyback for 665,000 shares, representing 0.72% for INR 598.5 million.	CI
24-08-25	Aarti Drugs Limited authorizes a Buyback Plan.	CI
24-08-21	Aarti Drugs Limited's Board intends to launch an Equity Buyback on August 26, 2024.	CI
24-08-02	Aarti Drugs Arm's Baddi, India Plant Gets Establishment Inspection Report from US FDA	MT
24-07-26	Aarti Drugs Limited Reports Earnings Results for the First Quarter Ended June 30, 2024	CI
24-05-03	Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI
24-05-03	Aarti Drugs Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024	CI
24-02-05	Ex-dividend day for interim dividend	FA
24-01-30	Aarti Drugs Begins Manufacturing Dermatology Products in Tarapur, India Facility	MT
24-01-30	Aarti Drugs Limited Initiates Commercial Production of Dermatology Product At New Facility in Tarapur, Maharashtra	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies Trading Ideas

Highlights Aarti Drugs Limited

Equities

AARTIDRUGS

INE767A01016

Pharmaceuticals

Highlights

Filters